The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2015

Filed:

Nov. 15, 2012
Applicant:

Industry-university Cooperation Foundation Hanyang University, Seongdong-gu, Seoul, KR;

Inventors:

Jeehee Youn, Seoul, KR;

Kyuheon Lee, Seoul, KR;

Sejin Hwang, Seoul, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); C07K 14/47 (2006.01); C07K 17/00 (2006.01); C07K 16/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); A61K 38/02 (2006.01); C07K 5/02 (2006.01); C07K 2/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/02 (2013.01); A61K 38/00 (2013.01); C07K 2/00 (2013.01); C07K 5/02 (2013.01); C07K 5/0215 (2013.01);
Abstract

Provided are a pharmaceutical use of poly-gamma-glutamic acid used for preventing or treating Th17-mediated diseases, a composition for preventing or treating Th17-mediated diseases comprising poly-gamma-glutamic acid as an active ingredient, and a method of preventing or treating Th17-mediated diseases using the same. The pharmaceutical composition is effective in inhibiting the differentiation of Th17 cells while promoting Treg cells, and, thus, can be useful in preventing or treating Th17-mediated diseases such as multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, Crohn's disease, ankylosing spondylitis, and the like.


Find Patent Forward Citations

Loading…